The latest breast cancer news, advice, and information, including treatment, genetics, symptoms, advanced stages, and real-life inspiring stories about people living with breast cancer.
"Dr. Hahn's bedside manner is what helps me stay as positive as I am."
Middle-aged women aren’t getting the message that there’s a proven link between alcohol consumption and higher breast cancer risk, say researchers.
Early detection and treatment for breast cancer have prevented hundreds of thousands of breast-cancer deaths in the United States in the past three decades.
Menopausal women who experience persistent hot flashes or night sweats are more likely to develop breast cancer than women who don’t have hot flashes.
Cancer changes bodies, and relationships. That doesn’t mean you have to give up intimacy and sex.
Here’s how you can find pain relief with a highly individualized combination of strategies.
It is normal for a cancer patient to feel sad. But depression is not normal — and it's treatable.
If you have metastatic breast cancer, how do you know if a clinical trial might be right for you? And what can you expect if you join one?
Metastatic breast cancer treatment can involve chemotherapy, radiation, and medication, which can cause nausea. Here are some solutions for this side effect.
Treatments for metastatic breast cancer can harm healthy tissue. Here's advice to ease those sometimes painful side effects.
Nancy Cappello's advocacy for breast density notification in mammogram reports resulted in legislation in 36 American states, a move that saves lives.
PJ Hamel is senior digital content editor and food writer at King Arthur Flour, and a James Beard award-winning author. A 16-year breast cancer survivor, her passion is helping women through this devastating disease.
This recent study suggests it might. The results showed that women with high vitamin D have one-fifth the rate of breast cancer than those with low vitamin D.
Researchers from the Mayo Clinic in Rochester, Minnesota, discovered that an FDA-approved treatment for certain cancers of the blood may significantly reduce the growth of triple-negative breast cancers.
This week, the U.S. Food and Drug Administration (FDA) authorized 23andMe to market the first direct-to-consumer test for three specific genetic mutations known to increase the risk for breast, ovarian, and prostate cancer. Called the Personal Genome ...